Mobia Medical Inc

MOBI USD0.01
Create an alert
Sell
0.00p
Buy
0.00p
No change
Last updated today at

To trade with this investment contact our helpdesk

Online trading unavailable

Back to dashboard

Company Information

About this company

Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.

Key people

Dana G. Mead
Independent Chairman of the Board
Edward Hanlon
Independent Director
William Harrington
Independent Director
Richard John Foust
President, Chief Executive Officer, Director
Thomas Jordan Curnes
President, Co-Founder
Nelson Bunker Curnes
Chief Financial Officer, Director
Prashant Rawat
Chief Operating Officer
Chase Leavitt
General Counsel, Corporate Secretary
Douglas T. Ellison
Chief Commercial Officer
Maxwell Bikoff
Independent Director
Myriam J. Curet
Independent Director
Click to see more

Key facts

  • Shares in issue
    33.29m
  • EPIC
    MOBI
  • ISIN
    US60705V1035
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    GBX 0.00
  • Employees
    167
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.